MediWound Ltd. (MDWD)

MediWound Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	35.57	41.71	33.9	11.05	17.38	7.24
Short-Term Investments	0	0	0	0	4.21	22.22
Cash & Cash Equivalents	35.57	41.71	33.9	11.05	21.58	29.46
Cash Growth	-37.82%	23.05%	206.85%	-48.82%	-26.73%	24.65%
Receivables	5.56	5.37	10.16	3.18	3.23	4.56
Inventory	3.31	2.85	1.96	1.2	1.38	1.61
Other Current Assets	-0.24	-0.23	-0.18	-0.47	0	0
Total Current Assets	44.2	49.7	45.84	14.95	26.19	35.63
Property, Plant & Equipment	17.35	15.93	3.58	4.03	4.51	4.53
Long-Term Investments	0.45	0.44	0.18	0	0	0
Goodwill and Intangibles	0.15	0.17	0.23	0.3	0.36	0.43
Other Long-Term Assets	0.24	0.23	0.18	0.47	0	0
Total Long-Term Assets	18.18	16.76	4.18	4.79	4.88	4.96
Total Assets	62.38	66.46	50.02	19.74	31.07	40.59
Accounts Payable	7.73	9.42	9.82	8.31	5.85	9.8
Deferred Revenue	0	0	0	0.12	1.23	1.14
Other Current Liabilities	14.61	8.71	2.24	2.29	1.18	-0.57
Total Current Liabilities	22.34	18.13	12.06	10.72	8.27	10.37
Long-Term Debt	6.47	6.35	3.63	5.31	1.74	2.01
Other Long-Term Liabilities	10.37	10.39	23.41	8.29	13.79	13.04
Total Long-Term Liabilities	16.84	16.74	27.05	13.61	15.53	15.05
Total Liabilities	39.18	34.86	39.1	24.33	23.8	25.42
Total Debt	6.47	6.35	3.63	5.31	1.74	2.01
Debt Growth	770.39%	74.74%	-31.60%	205.17%	-13.21%	1273.97%
Retained Earnings	-	-174.82	-168.11	-148.51	-134.96	-125.76
Comprehensive Income	0	0	-0.01	-0.02	-0.04	-0.02
Shareholders' Equity	23.2	31.6	10.91	-4.58	7.27	15.17
Net Cash / Debt	29.1	35.36	30.26	5.73	19.84	27.45
Net Cash / Debt Growth	-48.46%	16.84%	427.84%	-71.11%	-27.72%	16.88%
Net Cash Per Share	3.15	3.92	6.07	1.47	5.11	7.07
Working Capital	21.86	31.57	33.78	4.23	17.93	25.26
Book Value Per Share	2.51	3.50	2.19	-1.18	1.87	3.91

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).